Physician profile
Allan Jaffe
NPI 1538146626
$110,604.88
in general payments reported to CMS, 2019-2025
13 companies · $5,829 in 2025
The $5,829 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $33K · 2021: $10K · 2022: $12K · 2023: $9,892 · 2024: $19K · 2025: $5,829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Travel and Lodging: $12K · Food and Beverage: $1,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,433.16 |
| Travel and Lodging | $12,495.52 |
| Food and Beverage | $1,136.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $39,033.04 | 2019-2025 | Advia Centaur Xp Analyzer, Advia Chemistry Xpt System |
| Roche Diagnostics International LTD | $28,142.72 | 2021-2025 | |
| Abbott Laboratories | $13,573.04 | 2019-2023 | Xience Sierra, Optis |
| Amgen INC. | $11,775.00 | 2020 | |
| Roche Diagnostics Corporation | $8,374.47 | 2019-2022 | |
| Radiometer America, INC | $4,012.50 | 2020-2024 | |
| Modernatx, INC. | $3,000.00 | 2024 | |
| Beckman Coulter, INC. | $1,700.00 | 2019-2020 | |
| Ge Healthcare | $337.00 | 2023 | |
| Lumiradx, INC. | $300.00 | 2024 | |
| Philips North America LLC | $299.99 | 2024-2025 | Ecc Solutions, (Ck4) Mcot |
| Novo Nordisk INC | $57.12 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allan Jaffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.